Unknown

Dataset Information

0

5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma.


ABSTRACT: Primary hyperparathyroidism is characterized by enlarged parathyroid glands due to an adenoma (80-85 %) or multiglandular disease (~15 %) causing hypersecretion of parathyroid hormone (PTH) and generally hypercalcemia. Parathyroid cancer is rare (<1-5 %). The epigenetic mark 5-hydroxymethylcytosine (5hmC) is reduced in various cancers, and this may involve reduced expression of the ten-eleven translocation 1 (TET1) enzyme. Here, we have performed novel experiments to determine the 5hmC level and TET1 protein expression in 43 parathyroid adenomas (PAs) and 17 parathyroid carcinomas (PCs) from patients who had local invasion or metastases and to address a potential growth regulatory role of TET1.The global 5hmC level was determined by a semi-quantitative DNA immune-dot blot assay in a smaller number of tumors. The global 5hmC level was reduced in nine PCs and 15 PAs compared to four normal tissue samples (p?

SUBMITTER: Barazeghi E 

PROVIDER: S-EPMC4789293 | BioStudies | 2016-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC6060499 | BioStudies
2014-06-14 | E-GEOD-51902 | BioStudies
2014-01-01 | S-EPMC4164501 | BioStudies
2013-01-01 | S-EPMC3998089 | BioStudies
2016-01-01 | S-EPMC5021200 | BioStudies
2019-01-01 | S-EPMC6338639 | BioStudies
2011-01-01 | S-EPMC3154739 | BioStudies
2017-01-01 | S-EPMC5503132 | BioStudies
2015-10-30 | E-GEOD-61169 | ArrayExpress
2016-01-01 | S-EPMC4751095 | BioStudies